Dr. Chaitanya Borde

Dr Chaitanya Borde is a highly distinguished Senior Nuclear Medicine Physician in Nashik with 18 years of clinical experience.

He currently serves as a Consultant at the HCG Manavata Cancer Centre (Unit 2) in Mumbai Naka. His clinical focus is the administration of highly advanced radioactive isotopes designed to trace, map, and therapeutically destroy metabolic cancer cells throughout the body.

Dr Borde possesses an incredibly elite, apex-tier oncological pedigree. He completed his highly specialized training in Radiation Medicine at the prestigious Homi Bhabha National Institute (HBNI) and the world-renowned Tata Memorial Hospital (TMH) in Mumbai.

Serving at these apex-level nuclear physics and oncology centers provided Dr Borde with massive, high-volume exposure to the most complex, treatment-resistant malignancies in the country, guaranteeing his nuclear protocols meet the absolute highest global standards.

Demonstrating immense clinical authority, Dr Borde has successfully administered and evaluated over 30,000 PET-CT scans throughout his career, establishing him as one of the most experienced metabolic imaging experts in the region.

Furthermore, he has successfully treated over 1,000 thyroid cancer patients utilizing advanced high-dose radioiodine therapies, effectively hunting down and destroying metastatic thyroid cells that have spread to the bones and lungs.

Dr Borde is fluent in English, Hindi, and Marathi, allowing him to clearly communicate highly complex nuclear medicine protocols to a diverse patient demographic across Maharashtra.

Specialty Areas and Treatments

Dr Chaitanya Borde provides highly authoritative nuclear medicine services, integrating advanced metabolic imaging and therapeutic radiopharmaceuticals to manage highly aggressive solid and liquid tumors.

Advanced Diagnostic Nuclear Medicine (PET-CT)

Instead of just looking at the physical shadow of a tumor, Dr Borde injects radioactive sugar (FDG) into the patient to make live cancer cells biologically "glow" on a scanner:

• 18F-FDG PET-CT for Precise Cancer Staging and Restaging
• Gallium-68 (Ga-68) DOTATOC PET-CT for Neuroendocrine Tumors
• Gallium-68 (Ga-68) PSMA PET-CT for Prostate Cancer Evaluation

Targeted Radionuclide Therapy (Theranostics)

He executes highly aggressive, systemic therapies where radioactive liquid is injected into the bloodstream, acting like a "smart bomb" that exclusively targets and destroys cancer cells:

• Lutetium-177 (Lu-177) PSMA Therapy for Advanced Prostate Cancer
• Lutetium-177 (Lu-177) DOTATATE Therapy for Neuroendocrine Tumors
• High-Dose Radioiodine (I-131) Therapy for Metastatic Thyroid Carcinoma

Nuclear Cardiology and Organ Scans

Drawing on his elite Tata Memorial training, he utilizes specialized isotopes to evaluate the physiological function of the heart, kidneys, and bones:

• Myocardial Perfusion Imaging and Cardiac Viability Scans
• Evaluation of Chemotherapy-Induced Cardiotoxicity
• Whole-Body Bone Scans and Renal Scintigraphy (DTPA / DMSA)

Education and Qualifications

• MBBS — Maharashtra University of Health Sciences, Nashik (2008)
• Diploma in Radiation Medicine — Homi Bhabha National Institute, Mumbai (2010)
• DNB in Nuclear Medicine — National Board of Examinations, New Delhi (2013)

Research and Publications

• Radiotherapy and Oncology (2014) — Increasing cardiac 18F- fluorodeoxyglucose (FDG) uptake on PET-CT as a biomarker for cardiotoxicity of chemo-radiotherapy in cancer: a myth or a reality?
• Journal of Cancer Research and Therapeutics (2012) — Advantages of surgical extirpation in addition to radioiodine therapy in differentiated thyroid carcinoma patients with a solitary large-volume skeletal metastasis.
• World Journal of Radiology (2012) — Enhanced myocardial fluorodeoxyglucose uptake following Adriamycin-based therapy: Evidence of early chemotherapeutic cardiotoxicity?
• Nuclear Medicine Communications (2018) — 18F-FDG PET/CT in the evaluation of cancer cervix: Where do we stand today?

Professional Experience

Dr Chaitanya Borde currently practises at the following facility:

• Consultant in Nuclear Medicine, HCG Manavata Cancer Centre (Unit 2) in Mumbai Naka

Book an Appointment with Dr Chaitanya Borde

To book an appointment with Dr Chaitanya Borde or to check OPD timings and consultation details at HCG Manavata Cancer Centre (Unit 2) in Mumbai Naka in Nashik, connect with the HexaHealth team for assistance.